Homechevron_rightNewschevron_rightMedia Releasechevron_rightVaxxas Initiates Program With Merck to Optimize Delivery of Next Generation Vaccines Utilizing Novel Mechanism for Immune System Activation
Vaxxas Initiates Program With Merck to Optimize Delivery of Next Generation Vaccines Utilizing Novel Mechanism for Immune System Activation
Harro Höfliger and Vaxxas announce alliance to develop industrial‐scale aseptic processing line for vaccine products based on Vaxxas’ High Density Microarray Patch (HD‐MAP)
Clinical Genomics expands strategic relationship with Quest Diagnostics and further increases momentum for innovative first-line colorectal cancer screening blood test
